EGF and cancer: Epidermal growth factor (EGF) and Transforming growth factor beta 1 (TGF-β1) act as potent drivers of cancer progression through the induction of epithelial-mesenchymal transition (EMT), in which epithelial cells acquire a mesenchymal phenotype and gain cancer stem-cell-like properties [38].